Value through Innovation27 July 2016

Clinical Study Results

  • BI 1015550 - Healthy
    Clinical Study Number 1305.1
    Study Indication Healthy
    Product BI 1015550
    Generic Name BI 1015550
    Lab Code
    Clinical Phase I
    Study Title

    Safety, tolerability and pharmacokinetics of single rising oral doses of BI 1015550 in healthy male volunteers (a partially randomised, partially single-blind, placebo-controlled phase I study)

    Study Document Trial synopsis 1305.1_DS english
  • BI 1015550 - Healthy
    Clinical Study Number 1305.2
    Study Indication Healthy
    Product BI 1015550
    Generic Name BI 1015550
    Lab Code BI 1015550
    Clinical Phase I
    Study Title

    Safety, tolerability and pharmacokinetics of multiple rising oral doses of BI 1015550 powder for oral solution in healthy male volunteers q.d. or b.i.d.for 14 days (a randomised, double-blind, placebo-controlled within dose groups Phase I trial)

    Study Document Trial synopsis 1305.2 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.